###begin article-title 0
DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 307 317 307 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3 </italic>
The DDIT3 gene encodes a transcription factor belonging to the CCAAT/enhancer binding protein (C/EBP) family. It is normally expressed at very low levels but is activated by cellular stress conditions and induces G1 arrest and, in some cell types, apoptosis. DDIT3 is found as a part of the fusion oncogene FUS-DDIT3 that is causal for the development of myxoid/round-cell liposarcomas (MLS/RCLS).
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
In the present study, we searched for putative interaction partners of DDIT3 and the oncogenic FUS-DDIT3 among G1 cyclins and cyclin-dependent kinases. We found that FUS-DDIT3 and the normal DDIT3 bind CDK2. In addition, CDK2 showed an increased affinity for cytoskeletal proteins in cells expressing FUS-DDIT3 and DDIT3.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
We conclude that DDIT3 binds CDK2 and that many of the observed biological effects of DDIT3 may involve interaction with CDK2.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 7 20 7 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GADD153, CHOP</italic>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 504 505 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 600 602 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 745 747 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 748 750 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 819 821 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 874 876 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 877 879 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 972 974 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
DDIT3 (GADD153, CHOP) encodes a transcription factor belonging to the CCAAT/enhancer binding protein (C/EBP) family [1]. DDIT3 is normally transcribed at very low levels but is elevated upon DNA damage in cellular stress conditions [2-6]. The DDIT3 protein has a central role in endoplasmatic reticulum stress and DNA damage response by inducing cell cycle arrest and apoptosis [7,8]. DDIT3 has recently been implicated in the stress response leading to death of pancreatic insulin producing beta-cells [9] and it may also be a part of cellular stress conditions causing neurodegenerative disorders [10]. In addition, DDIT3 is believed to be involved in growth cessation and terminal differentiation of lipoblasts, osteoblasts and erythrocytes [11-13]. DDIT3 forms heterodimers with several other C/EBP family members [14] as well as other leucine zipper carrying proteins [15,16] and the heterodimers are believed to act as dominant negative inhibitors of transcription [14].
###end p 8
###begin p 9
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 220 226 220 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS </italic>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLS</italic>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EWSR1 </italic>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 753 755 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
DDIT3 is also a part of a fusion oncogene critical for the development of myxoid/round cell liposarcoma (MLS/RCLS) [17,18]. The tumor cells carry the chromosomal translocation t(12;16)(q13;p11) that results in fusion of DDIT3 to FUS (also called TLS) or more rarely the t(12;22)(q13;q12) that fuses DDIT3 to EWSR1 [19-21]. The chimerical FUS-DDIT3 oncoprotein functions as an abnormal transcription factor [22] and localizes to distinct nuclear structures in cultured cells [23,24]. MLS/RCLS cells exhibit abnormal expression profiles of cell cycle controlling factors and among them cyclins and cyclin-dependent kinases (CDKs) [25]. In addition, the DDIT3-binding C/EBPalpha has been shown to interact and inhibit the kinase activity of CDK2 and CDK4 [26]. Based on these observations, we searched for putative interaction partners of the oncogenic FUS-DDIT3 with G1 cyclins and CDKs as these might provide insight into the molecular mechanisms by which the chimerical oncoprotein induces malignancy.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
CDK2 and cyclin E colocalize with FUS-DDIT3
###end title 11
###begin p 12
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
HT1080 cells were transiently transfected with a FUS-DDIT3-GFP construct and colocalization between the ectopically expressed fusion oncoprotein and endogenous cyclin D1, cyclin E, CDK2 and CDK4 was investigated by immunofluorescence. Cyclin E and CDK2 showed prominent colocalization with the FUS-DDIT3 protein and were detected in FUS-DDIT3 containing granules in the majority of cells (Figure 1). We found no signs of colocalization between FUS-DDIT3 and CDK4 (Figure 1) or cyclin D1 (not shown). Cells transfected with the empty GFP vector showed no granules and a smooth nuclear distribution of CDK2 and cyclin E (Figure 1).
###end p 12
###begin p 13
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDK2 and cyclin E colocalize with FUS-DDIT3 in transiently transfected HT1080 cells</bold>
CDK2 and cyclin E colocalize with FUS-DDIT3 in transiently transfected HT1080 cells. The endogenous distribution of CDK2 and cyclin E seen in red is detected by antiserum specific for these proteins. Ectopically expressed GFP-tagged FUS-DDIT3 is shown in green. The DAPI dye is used to stain nuclei blue. CDK4 was not seen to accumulate in FUS-DDIT3-containing granules and no granules were formed in cells overexpressing the GFP protein only. Bars indicate 5 mum.
###end p 13
###begin title 14
FUS-DDIT3 binds CDK2 through its DDIT3 part
###end title 14
###begin p 15
###xml 28 37 28 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDK2 </italic>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDK2</italic>
###xml 572 582 572 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3 </italic>
###xml 585 591 585 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2a</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2a</xref>
###xml 992 1001 992 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
###xml 1003 1019 1003 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3&#916;LZ</italic>
###xml 1021 1027 1017 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 1138 1140 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2b</xref>
###xml 1617 1619 1605 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1629 1631 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2c</xref>
Cells were transfected with FUS-DDIT3-GFP and cellular proteins were immunoprecipitated with GFP antibodies and further analyzed by western blot. In pilot experiments, we used HT1080 cells stably expressing FUS-DDIT3-GFP and could weakly detect endogenous CDK2 in immunoprecipitates while cyclin E was not found (data not shown). To further confirm a possible interaction between FUS-DDIT3 and CDK2, we instead transiently transfected cells using cloned CDK2 cDNA expressed in frame with the fluorescent protein DsRed1. Cells co-transfected with CDK2-DsRed1 and either of FUS-DDIT3 or DDIT3 expressing constructs showed presence of CDK2-DsRed1 in anti-GFP immunoprecipitates from both FUS-DDIT3 and DDIT3 transfected cells (Figure 2a). In contrast, CDK2-DsRed1 was not found in immunoprecipitates of cells transfected with the N-terminal part of FUS present in the FUS-DDIT3 protein or in GFP-transfected control cells (Figure 2a). In a reverse experiment, HT1080 cells were transfected with FUS-DDIT3, FUS-DDIT3DeltaLZ, DDIT3 and GFP constructs and cellular proteins in extracts were immunoprecipitated with anti CDK2 antibodies (Figure 2b). We found that endogenous CDK2 co-immunoprecipitated with DDIT3, FUS-DDIT3 and FUS-DDIT3 lacking a leucine zipper domain. These results indicate that the region binding CDK2 is located N-terminally of the leucine zipper part of DDIT3. ClustalW alignment performed between DDIT3 and the related C/EBPalpha showed conservation of several amino acids in distinct regions shared by the two proteins but that DDIT3 lacks a region similar to the one that binds CDK2 in C/EBPalpha [26] (Figure 2c).
###end p 15
###begin p 16
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Co-immunoprecipitation of DDIT3 and CDK2</bold>
###xml 42 46 42 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a) </bold>
###xml 414 418 414 418 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b) </bold>
###xml 815 819 815 819 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(c) </bold>
Co-immunoprecipitation of DDIT3 and CDK2. (a) HT1080 cells were co-transfected with the indicated GFP constructs and CDK2-DsRed1. Proteins in cell lysates were further immunoprecipitated with anti GFP serum and recombinant CDK2-DsRed1 protein was detected by western blot using CDK2 antibodies. Input shows proteins before immunoprecipitation of cell lysates while IP shows proteins present in immunoprecipitates. (b) HT1080 cells were transiently transfected with the indicated GFP constructs and cellular proteins were immunoprecipitated with CDK2 antibodies. Recombinant proteins in samples were detected with anti GFP serum. The most intense bands in the input show the correct size of the GFP-tagged protein products while additional unspecific bands were also reacting with the GFP antisera in these samples. (c) ClustalW alignment of DDIT3 and C/EBPalpha amino acid sequences. A region shown to bind CDK2 in C/EBPalpha is boxed. Letters indicate standard amino acid abbreviations. Amino acids with related physicochemical characteristics are displayed below the sequences as: '*' (identical residue), ':' (highly similar residue), '.' (weakly similar residue). The leucine zipper region is seen towards the C-terminal in both proteins.
###end p 16
###begin title 17
CDK2 expression, phosphorylation status and turnover is not changed by FUS-DDIT3
###end title 17
###begin p 18
###xml 72 81 72 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
The CDK2 expression in HT1080 cells after 42 hours of transfection with FUS-DDIT3-GFP or GFP was investigated by western blot analysis (Figure 3). In addition, the phosphorylation status of CDK2 was analyzed using CDK2 antibodies targeting either the two inhibitory phosphorylations at threonine 14 and tyrosine 15 or the activating phosphorylation at threonine 160 (Figure 3). No apparent difference in CDK2 phosphorylation between cells expressing FUS-DDIT3-GFP or GFP was detected and the amount of CDK2 between the two transfected cell populations was equivalent (Figure 3). The CDK2 protein half-life did not differ between stably transfected FUS-DDIT3 cells and HT1080 control cells upon a six hour cycloheximide chase assay (not shown).
###end p 18
###begin p 19
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression and phosphorylation status of CDK2</bold>
###xml 132 141 132 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
Expression and phosphorylation status of CDK2. Western blot analysis of cell lysates from HT1080 cells transiently transfected with FUS-DDIT3-GFP and GFP. beta-actin is used as loading control.
###end p 19
###begin title 20
CDK2 protein binding affinity is altered in FUS-DDIT3 and DDIT3 expressing cells
###end title 20
###begin p 21
###xml 45 54 45 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 841 847 <span type="species:ncbi:9986">rabbit</span>
HT1080 cells were transfected with either of FUS-DDIT3, DDIT3 or GFP and CDK2 was immunoprecipitated from lysates with CDK2 specific antibodies (Figure 4). Precipitates were analyzed by SDS polyacrylamide gel electrophoresis and stained with Coomassie Blue. Several bands were present in the FUS-DDIT3 and DDIT3 precipitates that were absent in precipitates from GFP expressing cells (Figure 4). Bands from three regions were cut as indicated in the figure and analyzed by LC-MS/MS. The cytoskeletal cross-linker plectin (Figure 4, region 1), the actin motor-protein myosin (Figure 4, region 2) and the intermediary filament protein vimentin (Figure 4, region 3) were enriched in immunoprecipitates of FUS-DDIT3 and DDIT3 cells. The thicker bands with similar abundance in all three lanes in region 3 were identified by mass spectrometry as rabbit heavy chain immunoglobulin molecules.
###end p 21
###begin p 22
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3</italic>
###xml 132 141 132 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
###xml 0 163 0 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYPRO stained gel of co-immunoprecipitated proteins in extracts from HT1080 cells transiently transfected with either of <italic>DDIT3</italic>-GFP, <italic>FUS-DDIT3</italic>-GFP or GFP constructs</bold>
###xml 702 708 <span type="species:ncbi:9986">rabbit</span>
SYPRO stained gel of co-immunoprecipitated proteins in extracts from HT1080 cells transiently transfected with either of DDIT3-GFP, FUS-DDIT3-GFP or GFP constructs. CDK2 antibodies were used for immunoprecipitations. Boxes indicate regions of the gel analyzed by mass spectrometry. Three proteins were enriched in immunoprecipitates from DDIT3 and FUS-DDIT3 expressing cells (region 1: plectin, region 2: myosin, region 3: vimentin). Arrows indicate the differentially immunoprecipitated vimentin bands present in lanes of DDIT3 and FUS-DDIT3 cells but absent in that of GFP cells. These bands migrate slightly slower than the thicker bands inside the same region. The thicker bands were identified as rabbit heavy chain immunoglobulin molecules and these originate from the antibodies used for immunoprecipitation of CDK2 and are present in all three lanes.
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
In the present study, we used immunofluorescence microscopy to investigate putative colocalization between FUS-DDIT3 and cyclins/cyclin-dependent kinases involved in G1 cell cycle control. CDK2 and the CDK2 binding cyclin E were found to change their localization in FUS-DDIT3 expressing cells to a pattern that was identical to the FUS-DDIT3 nuclear granules reported earlier [24]. This suggests that CDK2 and cyclin E are translocated to nuclear structures defined by the FUS-DDIT3 protein. As the DDIT3 part is considered a DNA-binding transcription factor [27], we speculate that the FUS-DDIT3 defined structures may contain active chromatin and mRNA at different stages of processing. Thus, the accumulation of CDK2 and cyclin E to such nuclear regions may result in changed phosphorylation patterns and regulation of substrates present at these foci.
###end p 24
###begin p 25
###xml 98 100 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 175 177 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 628 630 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 640 642 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2c</xref>
DDIT3 is able to form DNA-binding heterodimers with C/EBPalpha through its leucine zipper region [14] and C/EBPalpha is reported to bind CDK2 and inhibit its kinase activity [26]. Therefore, it is possible that the binding between DDIT3 and CDK2 is mediated through C/EBPalpha or another C/EBP protein. However, we here show that a DDIT3 mutant lacking the leucine zipper domain binds CDK2, which implies a binding between DDIT3 and CDK2 that is independent of other C/EBP proteins. DDIT3 and C/EBPalpha contain several regions with sequence similarities but the proline-histidine rich part reported to bind CDK2 in C/EBPalpha [26] (Figure 2c) is not present in DDIT3. This suggests that DDIT3 binds CDK2 through a different mechanism than C/EBPalpha.
###end p 25
###begin p 26
###xml 249 251 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 801 810 793 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
###xml 812 818 804 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3 </italic>
###xml 1154 1156 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Analyses of GFP-immunoprecipitates failed to detect cyclin E in these samples. The absence of cyclin E in CDK2 immunoprecipitates bears resemblance to previous reports showing that C/EBPalpha disrupts CDK2/cyclin complexes leading to growth arrest [26]. Hence, it is possible that the DDIT3 bound to CDK2 disrupts CDK2/cyclin E complexes in similar way as C/EBPalpha. Consequently, since cyclin E is a major regulator of CDK2 kinase activity in G1, the DDIT3 binding may alter CDK2 activity in DDIT3 and FUS-DDIT3 expressing cells. We did however not detect a change in phosphorylation status of CDK2 in FUS-DDIT3 expressing cells compared to control cells. To further analyze the functional effects of DDIT3/FUS-DDIT3 binding to CDK2, we immunoprecipitated CDK2 in cells transiently transfected with FUS-DDIT3, DDIT3 and GFP constructs. Analysis of the precipitates revealed enhanced binding of CDK2 to components of the cytoskeleton in cells expressing FUS-DDIT3 and DDIT3. An increased affinity for cytoskeletal components and crosstalk between cell cycle proteins and cytoskeletal regulatory proteins could lead to changes in cytoskeleton structure [28].
###end p 26
###begin title 27
Conclusions
###end title 27
###begin p 28
In conclusion, we show that CDK2 is translocated to nuclear structures defined by the FUS-DDIT3 oncoprotein and that it binds the DDIT3 part of the chimera. Cyclin E is also recruited to FUS-DDIT3 nuclear structures but can not be found in CDK2-containing DDIT3/FUS-DDIT3 precipitates. The interaction of FUS-DDIT3 and DDIT3 with CDK2 appears to alter the binding affinity of CDK2, possibly leading to changed phosphorylation patterns and regulation of cytoskeletal or other proteins. Many of the observed biological effects of DDIT3 may involve the interaction with CDK2.
###end p 28
###begin title 29
Methods
###end title 29
###begin title 30
Cell culture and transfection
###end title 30
###begin p 31
###xml 189 190 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 103 109 <span type="species:ncbi:9913">bovine</span>
Human HT1080 fibrosarcoma cells were grown in RPMI 1640 medium (Sigma-Aldrich) supplied with 10% fetal bovine serum, penicillin (50 U/ml) and streptomycin (50 mug/ml) at 37degreesC in 5% CO2. Cells were transiently transfected at 50-70% confluence using the FuGENE 6 transfection reagent (Roche) with a 3:1 FuGENE:DNA ratio, according to the instructions supplied by the manufacturer.
###end p 31
###begin title 32
Immunofluorescence
###end title 32
###begin p 33
###xml 116 122 <span type="species:ncbi:9986">rabbit</span>
Cells were fixed 24 hours after transfection in 3.7% formaldehyde in PBS for 10 min, rinsed in PBS and stained with rabbit polyclonal antibodies for CDK2 (C5223, Sigma-Aldrich), CDK4 (C8218, Sigma-Aldrich), cyclin D1 (M7155, Dako) or cyclin E (C4976, Sigma-Aldrich) that were detected using Cy3 conjugated secondary antibodies (Fluorolink, Amersham Biosciences). Finally, slides were mounted using DAPI/DABCO solution (Sigma-Aldrich), incubated over night at room temperature and then imaged using a Zeiss LSM510 META confocal microscope system.
###end p 33
###begin title 34
Expression vectors
###end title 34
###begin p 35
###xml 316 325 316 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3</italic>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT3</italic>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUSA</italic>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 393 409 393 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUS-DDIT3&#916;LZ</italic>
###xml 552 554 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 623 625 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
For cloning of CDK2 the following primers were used: CDK2 forward GATCTCGAGCCACCATGGAGAACTTCCAAAAG, CDK2 reverse CAAGGATCCCGGAGTCGAAGATGGGGTACT. The CDK2 fragment was cloned into the pDsRed1-N1 vector (Clontech Laboratories) in frame with the DsRed1 sequence. All constructs were sequenced to exclude mutant clones. FUS-DDIT3-GFP, DDIT3-GFP and FUSA-GFP were previously described [24,29]. The FUS-DDIT3DeltaLZ-GFP construct, expressing a protein lacking the 38 most C-terminal amino acids (including the leucine zipper region), is described elsewhere [30]. Stably transfected FUS-DDIT3 cells has been described previously [31].
###end p 35
###begin title 36
Co-immunoprecipitation
###end title 36
###begin p 37
###xml 1501 1502 1491 1492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1504 1506 1494 1496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4 </sub>
###xml 612 618 <span type="species:ncbi:9913">bovine</span>
HT1080 cells were co-transfected with CDK2-DsRed and/or FUS-DDIT3-GFP/FUS-DDIT3-DeltaLZ/DDIT3-GFP/FUSA-GFP/GFP constructs at 50-70% confluence. Twenty-four hours post transfection, cells were washed in PBS, scraped and lysed in NP-40 buffer (150 mM NaCl, 1% NP-40, 50 mM Tris pH 8.0) containing protease inhibitor (Complete Mini, Roche). Debris was removed by centrifugation at 14,000 g and supernatants were used for co-immunoprecipitations. Two microgram of antibodies specific for GFP (8372-2, BD Pharmingen) or CDK2 (C5223, Sigma-Aldrich) were prebound to protein A agarose beads (Millipore) blocked with 5% bovine serum albumin in NP-40 buffer overnight. Cell lysates were incubated with antibody-beads mixtures for 4 h at room temperature. Beads were washed 5 times with NP-40 buffer and proteins were released from beads by addition of 4x NuPAGE LDS sample buffer (Invitrogen) and incubation at 95degreesC. Supernatants were subsequently analyzed with western blot or with SYPRO Ruby gel staining (Sigma-Aldrich) according to the instructions supplied by the manufacturer. SYPRO stained gels were analyzed by liquid chromatography-mass spectrometry (LC-MS/MS) at the Proteomics Core Facility at University of Gothenburg. For experiments with phospho-CDK2 antibodies (see below), transfected cells were lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton x-100, 1% Sodium deoxycholate, 0.1% SDS) containing protease inhibitors and phosphatase inhibitors (NaF 10 mM, Na3VO4 1 mM).
###end p 37
###begin title 38
Western Blot Analysis
###end title 38
###begin p 39
Proteins were separated using NuPAGE 4-12% Bis-Tris gels (Invitrogen), blotted onto PVDF membranes (Millipore) and probed with the following primary antibodies: CDK2 (sc-6248, Santa Cruz Biotechnology), p-CDK2 Thr14/Tyr15 (Santa Cruz Biotechnology), p-CDK2 Thr160 (Cell Signaling), cyclin E (C4976, Sigma-Aldrich), beta-actin (mAbcam8226, Abcam) and GFP (8371-2, BD Pharmingen). Primary antibodies were detected with alkaline phosphatase conjugated secondary antibodies (Dako) and bands were visualized with BCIP/NBT Alkaline Phosphatase Substrate (Sigma-Aldrich).
###end p 39
###begin title 40
ClustalW alignment
###end title 40
###begin p 41
###xml 146 148 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
The amino acid sequences of DDIT3 and C/EBPalpha were aligned using the ClustalW algorithm available at the Universal protein resource (UniProt) [32].
###end p 41
###begin title 42
Abbreviations
###end title 42
###begin p 43
CDK2: cyclin-dependent kinase 2; C/EBP: CCAAT/enhancer binding protein; CHOP: C/EBP homologous protein; DDIT3: DNA damage-inducible transcript 3; FUS: fusion; GFP: green fluorescent protein; LC-MS/MS: liquid chromatography mass spectrometry; MLS/RCLS: myxoid/round-cell liposarcoma; TLS: translocated in liposarcoma.
###end p 43
###begin title 44
Authors' contributions
###end title 44
###begin p 45
PA conceived of the study. CB, MKA and PA designed the experiments. CB and MKA performed research. CB, MKA and PA wrote the manuscript. All authors read and approved the final version of the manuscript.
###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
We thank Anita Olofsson and Farzaneh Alemirad for technical assistance. We acknowledge the Proteomics Core Facility at University of Gothenburg for mass spectrometric analyses. This work was supported by grants from the Swedish Cancer Society, Assar Gabrielssons Research Foundation and the Johan Jansson Foundation for Cancer Research.
###end p 47
###begin article-title 48
CCAAT/enhancer-binding proteins: structure, function and regulation
###end article-title 48
###begin article-title 49
Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents
###end article-title 49
###begin article-title 50
Regulation of the C/EBP-related gene gadd153 by glucose deprivation
###end article-title 50
###begin article-title 51
###xml 112 116 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Induction of GADD153, a CCAAT/enhancer-binding protein (C/EBP)-related gene, during the acute phase response in rats. Evidence for the involvement of C/EBPs in regulating its expression
###end article-title 51
###begin article-title 52
Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element
###end article-title 52
###begin article-title 53
Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153)
###end article-title 53
###begin article-title 54
CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest
###end article-title 54
###begin article-title 55
CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum
###end article-title 55
###begin article-title 56
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes
###end article-title 56
###begin article-title 57
Roles of CHOP/GADD153 in endoplasmic reticulum stress
###end article-title 57
###begin article-title 58
Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153)
###end article-title 58
###begin article-title 59
Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation
###end article-title 59
###begin article-title 60
CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation
###end article-title 60
###begin article-title 61
CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription
###end article-title 61
###begin article-title 62
Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10
###end article-title 62
###begin article-title 63
CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins
###end article-title 63
###begin article-title 64
Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma
###end article-title 64
###begin article-title 65
###xml 78 93 <span type="species:ncbi:10090">transgenic mice</span>
The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
###end article-title 65
###begin article-title 66
###xml 49 54 <span type="species:ncbi:9606">human</span>
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
###end article-title 66
###begin article-title 67
Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma
###end article-title 67
###begin article-title 68
Fusion of the EWS and CHOP genes in myxoid liposarcoma
###end article-title 68
###begin article-title 69
Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities
###end article-title 69
###begin article-title 70
Temperature-dependent localization of TLS-CHOP to splicing factor compartments
###end article-title 70
###begin article-title 71
The myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies
###end article-title 71
###begin article-title 72
Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas
###end article-title 72
###begin article-title 73
C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4
###end article-title 73
###begin article-title 74
Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element
###end article-title 74
###begin article-title 75
Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?
###end article-title 75
###begin article-title 76
The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response
###end article-title 76
###begin article-title 77
The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ
###end article-title 77
###begin article-title 78
Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression
###end article-title 78
###begin article-title 79
The universal protein resource (UniProt)
###end article-title 79

